Lowering low-density lipoprotein (LDL) cholesterol levels is among the most important issues in combatting with atherosclerotic diseases. Introduction of statins has launched a new era in this field. Trials conducted in the past 20 years have shown the effect of statins on improved survival, with accumulating evidence justifying the need for lowering the limits set for LDL cholesterol levels. In this review, target LDL cholesterol levels pertaining to statin use are discussed in different risk groups in view of relevant randomized controlled trials.
Keywords: Anticholesteremic agents/therapeutic use; cardiovascular diseases/prevention & control; hypercholesterolemia; lipoproteins, LDL cholesterol; myocardial infarction/drug therapy.Copyright © 2024 Archives of the Turkish Society of Cardiology